Nubeqa

Pharma

Bayer's pharma division sees one more year of declining sales

Bayer’s growth drivers—Nubeqa and Kerendia—are performing better than anticipated. But that won’t lead to growth of company's pharma business this year.

Kevin Dunleavy Mar 4, 2026 11:35am

Bayer sues J&J over 'deeply flawed' Erleada promotional claims

Feb 23, 2026 1:03pm

Bayer Highlights Real campaign Tony Romo

Bayer has Tony Romo calling plays in Nubeqa drive

Jan 29, 2026 10:40am

Bayer stays positive on newer meds as pharma sales stagnate

Nov 12, 2025 11:46am

Bayer has laid off over 12K during Bill Anderson's tenure as CEO

Aug 6, 2025 11:37am

FDA approves use of Bayer's Nubeqa in all patients with mCSPC

Jun 4, 2025 11:38am